EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients

Darío Sanchez-Cabrero, Álvaro Garcia-Guede, Miranda Burdiel, Olga Pernía iD, Julián Colmenarejo-Fernandez, Laura Gutierrez iD, Oliver Higuera, Isabel Esteban Rodriguez, Rocío Rosas-Alonso, Carlos Rodriguez-Antolín iD, Itsaso Losantos-García iD, Olga Vera iD und 2 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Darío Sanchez-Cabrero und 13 weiteren Autor:innen. Beteiligte Einrichtung: Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, 28046 Madrid, Spain. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, MicroRNAs, Exosomes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, CaixaBank, Fundación Mutua Madrileña.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advances in non-small cell lung cancer (NSCLC) research, this is still the most common cancer type that has been diagnosed up to date. microRNAs have emerged as useful clinical biomarkers in both tissue and liquid biopsy. However, there are no reliable predictive biomarkers for clinical use. We evaluated the preclinical use of seven candidate miRNAs previously identified by our group. We collected a total of 120 prospective samples from 88 NSCLC patients. miRNA levels were analyzed via qRT-PCR from tissue and blood samples. miR-124 gene target prediction was performed using RNA sequencing data from our group and interrogating data from 2952 NSCLC patients from two public databases. We found higher levels of all seven miRNAs in tissue compared to plasma samples, except for miR-124. Our findings indicate that levels of miR-124, both free-circulating and within exosomes, are increased throughout the progression of the disease, suggesting its potential as a marker of disease progression in both advanced and early stages. Our bioinformatics approach identified KPNA4 and SPOCK1 as potential miR-124 targets in NSCLC. miR-124 levels can be used to identify early-stage NSCLC patients at higher risk of relapse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMicroRNAsExosomesHumansPrognosisProspective StudiesBiomarkers, TumorNeoplasm Recurrence, LocalLiquid BiopsyProteoglycansalpha Karyopherins

Stichwörter der Autor:innen

NSCLCliquid biopsymiR-124sEVs

Substanzen

Biomarkers, TumorMicroRNAsSPOCK1 protein, humanProteoglycansKPNA4 protein, humanalpha KaryopherinsMIRN124 microRNA, human

Autor:innen und Institutionen

  • Biomarkers and Experimental Therapeutics in Cancer, IdiPAZ, 28046 Madrid, Spain.
  • Medical Oncology Department, La Paz University Hospital, 28046 Madrid, Spain.
  • Cancer Epigenetics Laboratory, INGEMM, La Paz University Hospital, 28046 Madrid, Spain.
  • Pathology Department, La Paz University Hospital, 28046 Madrid, Spain.
  • Biostatistics Unit, La Paz University Hospital, 28046 Madrid, Spain.

ORCID-Profile: Olga Pernía, Laura Gutierrez, Carlos Rodriguez-Antolín, Itsaso Losantos-García, Olga Vera, Javier De Castro-Carpeño, Inmaculada Ibanez de Caceres

Förderung

  • Instituto de Salud Carlos III
  • CaixaBank
  • Fundación Mutua Madrileña
  • ISCIII
  • Caixa-Impulse Validate program
  • Fundación Mutua Madrilena

Zitieren

APA

Sanchez-Cabrero, D., Garcia-Guede, Á., Burdiel, M., Pernía, O., Colmenarejo-Fernandez, J., Gutierrez, L., Higuera, O., Rodriguez, I. E., Rosas-Alonso, R., Rodriguez-Antolín, C., Losantos-García, I., Vera, O., De Castro-Carpeño, J., & Ibanez de Caceres, I. (2023). miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411464

Vancouver

Sanchez-Cabrero D, Garcia-Guede Á, Burdiel M, Pernía O, Colmenarejo-Fernandez J, Gutierrez L, et al. miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411464

BibTeX
@article{SanchezCabrero2023,
  author = {Sanchez-Cabrero, Darío and Garcia-Guede, Álvaro and Burdiel, Miranda and Pernía, Olga and Colmenarejo-Fernandez, Julián and Gutierrez, Laura and Higuera, Oliver and Rodriguez, Isabel Esteban and Rosas-Alonso, Rocío and Rodriguez-Antolín, Carlos and Losantos-García, Itsaso and Vera, Olga and De Castro-Carpeño, Javier and Ibanez de Caceres, Inmaculada},
  title = {miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411464}
}
Kostenlos starten →